Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Miller, T. R.
Right arrow Articles by Hancock, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, T. R.
Right arrow Articles by Hancock, A. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Analysis of Apparent Noncompetitive Responses to Competitive H1-Histamine Receptor Antagonists in Fluorescent Imaging Plate Reader-Based Calcium Assays

Thomas R. Miller

Neurological and Urological Disease Research; Genomics and Molecular Biology, Abbott Laboratories, Abbott Park, IL

David G. Witte

Neurological and Urological Disease Research; Genomics and Molecular Biology, Abbott Laboratories, Abbott Park, IL

Lynne M. Ireland

Neurological and Urological Disease Research; Genomics and Molecular Biology, Abbott Laboratories, Abbott Park, IL

Chae Hee Kang

Neurological and Urological Disease Research; Genomics and Molecular Biology, Abbott Laboratories, Abbott Park, IL

Jean M. Roch

Myriad Genetics, Salt Lake City, UT

Jeffrey N. Masters

Neurological and Urological Disease Research; Genomics and Molecular Biology, Abbott Laboratories, Abbott Park, IL

Timothy A. Esbenshade

Neurological and Urological Disease Research; Genomics and Molecular Biology, Abbott Laboratories, Abbott Park, IL

Arthur A. Hancock

Neurological and Urological Disease Research; Genomics and Molecular Biology, Abbott Laboratories, Abbott Park, IL

We have examined the utility of high throughput fluorescent imaging plate reader (FLIPR)-based calcium assays for pharmacological characterization of G-protein coupled receptors (GPCRs) using recombinant and native human H1-histamine receptors (H1-HR), expressed in HEK293 and HeLa S3 cells, respectively, as model systems. For stably transfected HEK293 cell lines, the potency of histamine for elevating intracellular calcium increased (pD2, 7.13 and 7.86) with increased H1-HR density (about 0.8 and 14 pmol/mg protein, respectively), though histamine binding affinities were similar. The classic H1-HR competitive antagonists diphenhydramine and chlorpheniramine appeared noncompetitive by causing depressions of the maximal histamine responses along with rightward shifts of histamine concentration-response curves, thus precluding Schild analysis. Applying the generalized Cheng-Prusoff equation to antagonist concentration-response curves for inhibition of fixed histamine concentrations yielded apparent pKb values that were consistent among recombinant and native receptors at different expression levels. These pKb values for diphenhydramine and chlorpheniramine (e.g., 7.83 and 8.77, respectively) were in good agreement with binding pKi values (e.g., 7.98 and 8.52, respectively). Apparent antagonist affinities determined from FLIPR calcium and competition binding assays were also consistent for the competitive antagonists mepyramine, tripelennamine, and promethazine. In phosphoinositide hydrolysis assays, chlorpheniramine exhibited insurmountable inhibition of histamine calcium responses, although to a lesser extent than that observed in calcium assays; pKb values were similar. These results demonstrate that competitive antagonist potencies can be attained from FLIPR-derived data by application of the generalized Cheng-Prusoff equation, despite apparent noncompetitive antagonism under these assay conditions. Apparent noncompetitive antagonist effects may in part be attributable to a lack of equilibrium of histamine and antagonists with H1-HR within the short duration of rapid transient effects of histamine on intracellular calcium.

Journal of Biomolecular Screening, Vol. 4, No. 5, 249-258 (1999)
DOI: 10.1177/108705719900400506


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. M. Krueger, D. G. Witte, L. Ireland-Denny, T. R. Miller, J. L. Baranowski, S. Buckner, I. Milicic, T. A. Esbenshade, and A. A. Hancock
G Protein-Dependent Pharmacology of Histamine H3 Receptor Ligands: Evidence for Heterogeneous Active State Receptor Conformations
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 271 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. P. Fitzsimons, F. Monczor, N. Fernandez, C. Shayo, and C. Davio
Mepyramine, a Histamine H1 Receptor Inverse Agonist, Binds Preferentially to a G Protein-coupled Form of the Receptor and Sequesters G Protein
J. Biol. Chem., August 13, 2004; 279(33): 34431 - 34439.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
Y. Zhang, D. Kowal, A. Kramer, and J. Dunlop
Evaluation of FLIPR Calcium 3 Assay Kit--A New No-Wash Fluorescence Calcium Indicator Reagent
J Biomol Screen, October 1, 2003; 8(5): 571 - 577.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Singh and H. K. Saini
Resident Cardiac Mast Cells and Ischemia-Reperfusion Injury
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 135 - 148.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
M. U. Kassack, B. Hofgen, J. Lehmann, N. Eckstein, J. M. Quillan, and W. Sadee
Functional Screening of G Protein--Coupled Receptors by Measuring Intracellular Calcium with a Fluorescence Microplate Reader
J Biomol Screen, June 1, 2002; 7(3): 233 - 246.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
G. Kaler, M. Otto, A. Okun, and I. Okun
Serotonin Antagonist Profiling on 5HT2A and 5HT2C Receptors by Nonequilibrium Intracellular Calcium Response Using an Automated Flow-Through Fluorescence Analysis System, HT-PS(R)0
J Biomol Screen, June 1, 2002; 7(3): 291 - 301.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
K. Moore and S. Rees
Cell-Based Versus Isolated Target Screening: How Lucky Do You Feel?
J Biomol Screen, April 1, 2001; 6(2): 69 - 74.
[PDF]